Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Foods ; 12(2)2023 Jan 09.
Artículo en Inglés | MEDLINE | ID: covidwho-2215751

RESUMEN

In recent years, research on the interaction between flavonoids and intestinal microbes have prompted a rash of food science, nutriology and biomedicine, complying with future research trends. The gut microbiota plays an essential role in the maintenance of intestinal homeostasis and human health, but once the intestinal flora dysregulation occurs, it may contribute to various diseases. Flavonoids have shown a variety of physiological activities, and are metabolized or biotransformed by gut microbiota, thereby producing new metabolites that promote human health by modulating the composition and structure of intestinal flora. Herein, this review demonstrates the key notion of flavonoids as well as intestinal microbiota and dysbiosis, aiming to provide a comprehensive understanding about how flavonoids regulate the diseases by gut microbiota. Emphasis is placed on the microbiota-flavonoid bidirectional interaction that affects the metabolic fate of flavonoids and their metabolites, thereby influencing their metabolic mechanism, biotransformation, bioavailability and bioactivity. Potentially by focusing on the abundance and diversity of gut microbiota as well as their metabolites such as bile acids, we discuss the influence mechanism of flavonoids on intestinal microbiota by protecting the intestinal barrier function and immune system. Additionally, the microbiota-flavonoid bidirectional interaction plays a crucial role in regulating various diseases. We explain the underlying regulation mechanism of several typical diseases including gastrointestinal diseases, obesity, diabetes and cancer, aiming to provide a theoretical basis and guideline for the promotion of gastrointestinal health as well as the treatment of diseases.

2.
Microbiol Spectr ; 10(5): e0322222, 2022 Oct 26.
Artículo en Inglés | MEDLINE | ID: covidwho-2029477

RESUMEN

Rapid identification and continuous surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are critical for guiding the response to the COVID-19 pandemic. Whole-genome sequencing (WGS) is a preferred tool for this aim, but many laboratories suffer from a lack of resources to support population-level sequencing. Here, we describe two PCR strategies targeting spike protein mutations to identify the Alpha, Delta, and Omicron variants. Signature mutations were selected using a dedicated bioinformatic program. The selected mutations in Alpha and Delta variants were detected using multicolor melting curve analysis (MMCA). Thirty-two mutations of the Omicron variant were targeted using the MeltArray approach in one reaction, which was able to detect the Omicron subvariants BA.1, BA.2, BA.3, and BA.4/5. The limits of detection varied from five to 50 copies of RNA templates/reactions. No cross-reactivity was observed with nine other respiratory viruses, including other coronaviruses. We validated the MMCA and MeltArray assays using 309 SARS-CoV-2 positive samples collected at different time points. These assays exhibited 98.3% to 100% sensitivity and 100% specificity compared with WGS. Multiplexed real-time PCR strategies represent an alternative tool capable of identifying current SARS-CoV-2 VOCs, adaptable for emerging variants and accessible for laboratories using existing equipment and personnel. IMPORTANCE Rapid detection and mutation surveillance of SARS-CoV-2 VOCs is crucial for COVID-19 control, management, and prevention. We developed two rapid molecular assays based on the real-time PCR platform to identify important variants of concern, including the Omicron variant with a large number of mutations. Signature mutations were selected by an R program. Then, MMCA assays were established for Alpha and Delta variants, and a MeltArray assay targeting 32 mutations was developed for Omicron variant. These multiplexed PCR assays could be performed in a 96-well real-time PCR instrument within 2.5 h, offering a high-throughput choice for dynamic monitoring of SARS-CoV-2 VOCs in a standard microbiology laboratory.


Asunto(s)
COVID-19 , SARS-CoV-2 , Humanos , SARS-CoV-2/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , ARN Viral/genética , ARN Viral/análisis , Pandemias , Glicoproteína de la Espiga del Coronavirus/genética , COVID-19/diagnóstico , Mutación
3.
Epidemiologic Methods ; (s1)2022.
Artículo en Inglés | ProQuest Central | ID: covidwho-2002349

RESUMEN

To determine the point prevalence of undergraduate students who are hesitant to accept COVID-19 vaccination and to identify the predictors of COVID-19 vaccine hesitancy in university students.A cross-sectional study was conducted during June–July 2021. A total of 542 undergraduate students from universities in three central provinces of Thailand participated in an online survey via Google Form. We used a transculturally translated, Thai version of the Oxford Coronavirus Explanations, Attitudes, and Narratives Survey (OCEANS II).There were 217 undergraduate students (40%) who were hesitant to receive the COVID-19 vaccine and the significant predictors for this hesitancy were: being students in Year 2 and higher (AOR: 2.73;95% CI: 1.55–4.84);having negative beliefs toward the COVID-19 vaccine (AOR: 10.99;95% CI: 6.82–17.73);and having a perceived positive general vaccine conspiracy belief (AOR: 1.90;95% CI: 1.02–3.52).It is important to minimize vaccine hesitancy among Thai undergraduate students with a negative perception of vaccines by clarifying false information.

4.
International Journal of Organizational Innovation (Online) ; 14(2):85-105, 2021.
Artículo en Inglés | ProQuest Central | ID: covidwho-1515948

RESUMEN

In recent years, the world has been ravaged by Covid-19. Many physical shopping has to be converted to online shopping. The 82% of households in Taiwan have access to the Internet. It has become a habit for people to search for information or shop online. This has not only caused a surge in online shopping opportunities, but also, the government and private enterprises must also cater to the changing habits of consumers. Among them, the Internet community is the part with the highest proportion of people using the Internet. Therefore, not only business must pay attention to the operation of the community, but government departments also need to rely on the community to disseminate information. This study takes government department in southern Taiwan as an example to explore the effectiveness of the department's use of online communities to market leisure agriculture and experiential activities, and adopts Rogers' the- ory of innovation diffusion to illustrate how this innovation is diffused and whether it can effectively affect people's lives. Online and paper data collection methods were used, and total of 321 valid questionnaires were collected. The results show that innovation diffusion factors do significantly and positively affect people's attitudes towards leisure agriculture and positively increase satisfaction. This study is also discussed in the article, and provides consideration for relevant departments in their governance.

6.
J Med Virol ; 92(10): 2152-2158, 2020 10.
Artículo en Inglés | MEDLINE | ID: covidwho-260279

RESUMEN

The coronavirus disease 2019 (COVID-19) has evolved into a pandemic rapidly. Most of the literature show that the elevated liver enzymes in COVID-19 are of little clinical significance. Lower albumin level is seen in severe COVID-19 and is not parallel to the changes in alanine aminotransferase and aspartate aminotransferase levels. We aimed to explore the impact of hypoalbuminemia in COVID-19. This retrospective cohort study included adult patients with confirmed COVID-19. The relationship between hypoalbuminemia and death was studied using binary logistic analysis. A total of 299 adult patients were included, 160 (53.5%) were males and the average age was 53.4 ± 16.7 years. The median time from the onset of illness to admission was 3 days (interquartile ranges, 2-5). Approximately one-third of the patients had comorbidities. Hypoalbuminemia (<35 g/L) was found in 106 (35.5%) patients. The difference in albumin was considerable between survivors and non-survivors (37.6 ± 6.2 vs 30.5 ± 4.0, P < .001). Serum albumin level was inversely correlated to white blood cell (r = -.149, P = .01) and neutrophil to lymphocyte ratio (r = -.298, P < .001). Multivariate analysis showed the presence of comorbidities (OR, 6.816; 95% CI, 1.361-34.133), lymphopenia (OR, 13.130; 95% CI, 1.632-105.658) and hypoalbuminemia (OR, 6.394; 95% CI, 1.315-31.092) were independent predictive factors for mortality. In conclusion, hypoalbuminemia is associated with the outcome of COVID-19. The potential therapeutic value of albumin infusion in COVID-19 should be further explored at the earliest.


Asunto(s)
COVID-19/diagnóstico , Hospitalización/estadística & datos numéricos , Hipoalbuminemia/complicaciones , Adulto , Factores de Edad , Anciano , COVID-19/fisiopatología , China , Comorbilidad , Registros Electrónicos de Salud , Femenino , Humanos , Hepatopatías/sangre , Hepatopatías/complicaciones , Masculino , Persona de Mediana Edad , Análisis Multivariante , Estudios Retrospectivos , Factores de Riesgo
7.
J Med Virol ; 92(10): 2074-2080, 2020 10.
Artículo en Inglés | MEDLINE | ID: covidwho-175876

RESUMEN

The coronavirus disease 2019 (COVID-19) has evolved into a pandemic rapidly. The majority of COVID-19 patients are with mild syndromes. This study aimed to develop models for predicting disease progression in mild cases. The risk factors for the requirement of oxygen support in mild COVID-19 were explored using multivariate logistic regression. Nomogram as visualization of the models was developed using R software. A total of 344 patients with mild COVID-19 were included in the final analysis, 45 of whom progressed and needed high-flow oxygen therapy or mechanical ventilation after admission. There were 188 (54.7%) males, and the average age of the cohort was 52.9 ± 16.8 years. When the laboratory data were not included in multivariate analysis, diabetes, coronary heart disease, T ≥ 38.5℃ and sputum were independent risk factors of progressive COVID-19 (Model 1). When the blood routine test was included the CHD, T ≥ 38.5℃ and neutrophil-to-lymphocyte ratio were found to be independent predictors (Model 2). The area under the receiver operator characteristic curve of model 2 was larger than model 1 (0.872 vs 0.849, P = .023). The negative predictive value of both models was greater than 96%, indicating they could serve as simple tools for ruling out the possibility of disease progression. In conclusion, two models comprised common symptoms (fever and sputum), underlying diseases (diabetes and coronary heart disease) and blood routine test are developed for predicting the future requirement of oxygen support in mild COVID-19 cases.


Asunto(s)
COVID-19/patología , COVID-19/virología , Progresión de la Enfermedad , Femenino , Humanos , Linfocitos/patología , Masculino , Persona de Mediana Edad , Análisis Multivariante , Neutrófilos/patología , Pandemias , Neumonía Viral/patología , Neumonía Viral/virología , Curva ROC , Estudios Retrospectivos , Factores de Riesgo , SARS-CoV-2/patogenicidad
8.
Am J Transplant ; 20(7): 1879-1881, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: covidwho-101378

RESUMEN

Coronavirus Disease 2019 (COVID-19) has become a pandemic since March 2020. We describe here 2 cases of COVID-19 infection in a posttransplant setting. First one is a 59-year-old renal transplant recipient; the second is a 51-year-old allogeneic bone marrow transplant recipient. Both patients were on immunosuppressant therapy and had stable graft function before COVID-19 infection. After the diagnosis of COVID-19, immunosuppressive agents were discontinued and methylprednisolone with prophylactic antibiotics were initiated, however, the lung injury progressed. The T cells were extremely low in both patients after infection. Both patients died despite the maximal mechanical ventilatory support. Therefore, the prognosis of COVID-19 pneumonia following transplantation is not optimistic and remains guarded. Lower T cell count may be a surrogate for poor outcome.


Asunto(s)
Trasplante de Médula Ósea , Infecciones por Coronavirus/complicaciones , Fallo Renal Crónico/complicaciones , Trasplante de Riñón , Leucemia Mieloide Aguda/complicaciones , Neumonía Viral/complicaciones , Receptores de Trasplantes , Antibacterianos/administración & dosificación , Infecciones Bacterianas/complicaciones , COVID-19 , China , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/terapia , Infección Hospitalaria/complicaciones , Resultado Fatal , Humanos , Inmunosupresores/administración & dosificación , Fallo Renal Crónico/cirugía , Leucemia Mieloide Aguda/terapia , Masculino , Metilprednisolona/administración & dosificación , Persona de Mediana Edad , Pandemias , Neumonía Viral/diagnóstico , Neumonía Viral/terapia , Complicaciones Posoperatorias , Pronóstico , Respiración Artificial , Linfocitos T/citología
9.
J Med Virol ; 92(10): 1915-1921, 2020 10.
Artículo en Inglés | MEDLINE | ID: covidwho-60280

RESUMEN

Comorbidities are associated with the severity of coronavirus disease 2019 (COVID-19). This meta-analysis aimed to explore the risk of severe COVID-19 in patients with pre-existing chronic obstructive pulmonary disease (COPD) and ongoing smoking history. A comprehensive systematic literature search was carried out to find studies published from December 2019 to 22 March 2020 from five databases. The languages of literature included English and Chinese. The point prevalence of severe COVID-19 in patients with pre-existing COPD and those with ongoing smoking was evaluated with this meta-analysis. Overall 11 case series, published either in Chinese or English language with a total of 2002 cases, were included in this study. The pooled OR of COPD and the development of severe COVID-19 was 4.38 (fixed-effects model; 95% CI: 2.34-8.20), while the OR of ongoing smoking was 1.98 (fixed-effects model; 95% CI: 1.29-3.05). There was no publication bias as examined by the funnel plot and Egger's test (P = not significant). The heterogeneity of included studies was moderate for both COPD and ongoing smoking history on the severity of COVID-19. COPD and ongoing smoking history attribute to the worse progression and outcome of COVID-19.


Asunto(s)
COVID-19/fisiopatología , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Fumar/efectos adversos , COVID-19/complicaciones , Comorbilidad , Progresión de la Enfermedad , Humanos
10.
Liver Int ; 40(6): 1321-1326, 2020 06.
Artículo en Inglés | MEDLINE | ID: covidwho-27347

RESUMEN

BACKGROUND & AIMS: Coronavirus disease 2019 (COVID-19) has raised world concern for global epidemic since December, 2019. Limited data are available for liver function in COVID-19 patients. We aimed to investigate the risk factors related to liver injury in the COVID-19 patients. METHODS: A retrospective study was performed in non-ICU Ward at Jinyintan Hospital from February 2, 2020 to February 23, 2020. Consecutively confirmed COVID-19 discharged cases were enrolled. The clinical characteristics of patients with liver injury and without liver injury were compared. RESULTS: A total of 79 COVID-19 patients were included. 31.6%, 35.4% and 5.1% COVID-19 patients had elevated levels of alanine transaminase (ALT), aspartate aminotransferase (AST) and bilirubin respectively. Median value of ALT, AST and bilirubin for entire cohort was 36.5 (17.5 ~ 71.5) U/L, 34.5 (25.3 ~ 55.3) U/L and 12.7 (8.1 ~ 15.4) mmol/L respectively. There were no significant differences in age, previous medical history and symptoms between the two groups. Males were more likely to have liver injury when infected with COVID-19 (P < .05); compared with patients without liver injury, patients with liver injury had increased levels of white blood cell counts, neutrophils, CRP and CT score (P < .05) and had a longer length of stay (P < .05). Logistic regression analyses suggested that the extent of pulmonary lesions on CT was a predictor of liver function damage (P < .05). CONCLUSIONS: Liver injury is common in non-ICU hospitalized COVID-19 patients. It may be related to systemic inflammation. Intense monitoring and evaluation of liver function in patients with severe pulmonary imaging lesions should be considered.


Asunto(s)
Betacoronavirus/aislamiento & purificación , Infecciones por Coronavirus , Hepatopatías , Pruebas de Función Hepática/métodos , Pandemias , Neumonía Viral , Alanina Transaminasa/sangre , Aspartato Aminotransferasas/sangre , Bilirrubina/sangre , COVID-19 , China/epidemiología , Infecciones por Coronavirus/sangre , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Femenino , Hospitalización/estadística & datos numéricos , Humanos , Hepatopatías/sangre , Hepatopatías/diagnóstico , Hepatopatías/epidemiología , Hepatopatías/etiología , Pulmón/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Neumonía Viral/sangre , Neumonía Viral/complicaciones , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , Neumonía Viral/etiología , Prevalencia , Factores de Riesgo , SARS-CoV-2 , Tomografía Computarizada por Rayos X/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA